Swaran Nandini

Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein

Susanne Höing, Ting‐Yu Yeh, Matthias Baumann et al. · Cell chemical biology · 2018 · 84 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A novel mouse model carrying a human cytoplasmic dynein mutation shows motor behavior deficits consistent with Charcot-Marie-Tooth type 2O disease

Thywill T. Sabblah, Swaran Nandini, Aaron P. Ledray et al. · Scientific Reports · 2018 · 25 citations · Full text

Medicine, Molecular Genetics, Neurology +14

Analyses of Dynein Heavy Chain Mutations Reveal Complex Interactions Between Dynein Motor Domains and Cellular Dynein Functions

Senthilkumar Sivagurunathan, Robert R. Schnittker, David Razafsky et al. · Genetics · 2012 · 17 citations · Full text

Life Sciences, Biology, Molecular Biology +17

A mouse neurodegenerative dynein heavy chain mutation alters dynein motility and localization in <i>Neurospora crassa</i>

Senthilkumar Sivagurunathan, Robert R. Schnittker, Swaran Nandini et al. · Cytoskeleton · 2012 · 13 citations · Full text

Life Sciences, Cell Biology, Neuroscience +17

Mice with an autosomal dominant Charcot-Marie-Tooth type 2O disease mutation in both dynein alleles display severe moto-sensory phenotypes

Swaran Nandini, Jami L. Conley Calderon, Thywill T. Sabblah et al. · Scientific Reports · 2019 · 11 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17